Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Ebert

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
Psychopharmacology Bulletin|January 1, 1985
Disturbances of norepinephrine metabolism and alpha-2 adrenergic receptor activity in anorexia nervosa: relationship to nutritional stateW H Kaye, H E Gwirtsman, C R Lake, et al.
Chemical & Pharmaceutical Bulletin|January 20, 1998
Synthesis and radiolabeling of (S)-4-amino-5-iodo-2-methoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide, the active enantiomer of [125I]iodozacopride, and re-evaluation of its 5-HT3 receptor affinityW A Hewlett, T de Paulis, N S Mason, et al.
Pharmacology, Biochemistry, and Behavior|August 18, 2001
Anxiolytic-like effects of DAIZAC, a selective high-affinity 5-HT(3) receptor antagonist, in the mouse elevated plus-mazeZ J Zhang, D E Schmidt, T de Paulis, et al.
Clinical Science (London, England : 1979)|December 1, 1980
Dissociation between central and peripheral noradrenergic activity in essential hypertensionC R Lake, R J Polinsky, H G Güllner, et al.
Psychiatry Research|December 1, 1979
Chronic Parkinsonism secondary to intravenous injection of meperidine analoguesG C Davis, A C Williams, S P Markey, et al.
The American Journal of Psychiatry|August 1, 1982
d-Amphetamine-induced heterogeneous changes in psychotic behavior in schizophreniaD P van Kammen, W E Bunney, J P Docherty, et al.
Life Sciences|November 2, 1987
Reduced cerebrospinal fluid levels of immunoreactive pro-opiomelanocortin related peptides (including beta-endorphin) in anorexia nervosaW H Kaye, W H Berrettini, H E Gwirtsman, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 23, 1998
Characterization of (S)-des-4-amino-3-[125I]iodozacopride ([125I]DAIZAC), a selective high-affinity radioligand for 5-hydroxytryptamine3 receptorsW A Hewlett, B L Trivedi, Z J Zhang, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1987
Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depressionW H Kaye, H E Gwirtsman, D T George, et al.
Journal of Clinical Psychopharmacology|December 10, 1999
Preferential cerebrospinal fluid acetylcholinesterase inhibition by rivastigmine in humansJ S Kennedy, R J Polinsky, B Johnson, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Psychopharmacology Bulletin|January 1, 1985
Disturbances of norepinephrine metabolism and alpha-2 adrenergic receptor activity in anorexia nervosa: relationship to nutritional stateW H Kaye, H E Gwirtsman, C R Lake, et al.
Chemical & Pharmaceutical Bulletin|January 20, 1998
Synthesis and radiolabeling of (S)-4-amino-5-iodo-2-methoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide, the active enantiomer of [125I]iodozacopride, and re-evaluation of its 5-HT3 receptor affinityW A Hewlett, T de Paulis, N S Mason, et al.
Pharmacology, Biochemistry, and Behavior|August 18, 2001
Anxiolytic-like effects of DAIZAC, a selective high-affinity 5-HT(3) receptor antagonist, in the mouse elevated plus-mazeZ J Zhang, D E Schmidt, T de Paulis, et al.
Clinical Science (London, England : 1979)|December 1, 1980
Dissociation between central and peripheral noradrenergic activity in essential hypertensionC R Lake, R J Polinsky, H G Güllner, et al.
Psychiatry Research|December 1, 1979
Chronic Parkinsonism secondary to intravenous injection of meperidine analoguesG C Davis, A C Williams, S P Markey, et al.
The American Journal of Psychiatry|August 1, 1982
d-Amphetamine-induced heterogeneous changes in psychotic behavior in schizophreniaD P van Kammen, W E Bunney, J P Docherty, et al.
Life Sciences|November 2, 1987
Reduced cerebrospinal fluid levels of immunoreactive pro-opiomelanocortin related peptides (including beta-endorphin) in anorexia nervosaW H Kaye, W H Berrettini, H E Gwirtsman, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 23, 1998
Characterization of (S)-des-4-amino-3-[125I]iodozacopride ([125I]DAIZAC), a selective high-affinity radioligand for 5-hydroxytryptamine3 receptorsW A Hewlett, B L Trivedi, Z J Zhang, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1987
Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depressionW H Kaye, H E Gwirtsman, D T George, et al.
Journal of Clinical Psychopharmacology|December 10, 1999
Preferential cerebrospinal fluid acetylcholinesterase inhibition by rivastigmine in humansJ S Kennedy, R J Polinsky, B Johnson, et al.
Pageof 14